D
grade
De novo cardiomyocytes from within the activated adult heart after injury.
TB-500 (Thymosin Beta-4 Fragment) · Nature · 2011Top journal
Not reported in abstract.
Research library
Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.
2423studies indexed1086with human data145registered trials2091carry a numeric findingLibrarian added 0 studies today
Showing 9 studiesSortNewest indexed ▾
C
grade
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.
TB-500 (Thymosin Beta-4 Fragment) · Nature · 2012Top journal
Not reported in abstract.
C
grade
JMB2403, a potential best-in-class PD-1-dependent IL2Rβγ-activating tri-specific antibody for safe and potent immunotherapy.
TB-500 (Thymosin Beta-4 Fragment) · mAbs · 2026 · Observational · Preclinical
JMB2403 shows promise in activating T cells and enhancing anti-tumor efficacy without significant IL-2-related toxicities, but further research is needed to confirm these findings in humans.
Not reported in abstract.
B
grade
OTUD5 promotes AML progression by stabilizing SLC7A11 to suppress ferroptosis.
TB-500 (Thymosin Beta-4 Fragment) · Cell cycle (Georgetown, Tex.) · 2026 · Observational
OTUD5 enhances SLC7A11 stability in AML, suppressing ferroptosis and potentially contributing to treatment resistance.
Not reported in abstract.
B
grade
Construction and validation of a prediction model for graft failure in pediatric liver transplant recipients based on the APRI-ALBI score: a retrospective study of 289 cases.
TB-500 (Thymosin Beta-4 Fragment) · Annals of medicine · 2026 · Observational · n=289
The APRI-ALBI-based nomogram shows promise for predicting graft failure in pediatric liver transplant recipients, with an AUC of 0.706 and significant findings in Kaplan-Meier analysis.
AUC of 0.706 for the nomogram predicting graft failure.
C
grade
Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review
TB-500 (Thymosin Beta-4 Fragment) · biorxiv-preprint · 2026 · Review · Preclinical
The literature on Thymosin Beta-4 and TB-500 shows significant interest but is largely preclinical, with limited human evidence for musculoskeletal applications.
Not reported in abstract.
D
grade
Semantic Scholar search for TB-500 (Thymosin Beta-4)
TB-500 (Thymosin Beta-4 Fragment) · SemanticScholar · 2026
Not reported in abstract.
C
grade
Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential.
TB-500 (Thymosin Beta-4 Fragment) · PubMed · 2012
This study identifies a specific fragment of thymosin beta 4 in TB-500 and suggests methods for its detection, but does not provide evidence of its effects or clinical significance.
Not reported in abstract.
C
grade
Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.
TB-500 (Thymosin Beta-4 Fragment) · PubMed · 2012 · Observational
This study successfully detected TB-500 and its metabolites in equine samples, with significant findings at very low concentrations.
N-acetylated LKKTETQ detected at 0.02 ng/mL in equine plasma.
Showing 9 of 9